Gilboa-Geffen et al. showed that EpCAMiC is specifically taken up by EpCAM-positive cancer cell lines and in human EpCAM-positive breast cancer biopsies, where it silences the expression of PLK1 [187]. This evidence concerns the gene EPCAM and cancer.